These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28439676)

  • 1. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
    Takuwa T; Hashimoto M; Matsumoto S; Kondo N; Kuribayash K; Nakano T; Hasegawa S
    Int J Clin Oncol; 2017 Oct; 22(5):857-864. PubMed ID: 28439676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Ann Thorac Cardiovasc Surg; 2018 Apr; 24(2):81-88. PubMed ID: 29367501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
    Soldera SV; Kavanagh J; Pintilie M; Leighl NB; de Perrot M; Cho J; Hope A; Feld R; Bradbury PA
    Oncologist; 2019 Jul; 24(7):e510-e517. PubMed ID: 30478189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.
    Rea F; Marulli G; Bortolotti L; Breda C; Favaretto AG; Loreggian L; Sartori F
    Lung Cancer; 2007 Jul; 57(1):89-95. PubMed ID: 17403553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological complete response in malignant pleural mesothelioma patients following induction chemotherapy: Predictive factors and outcomes.
    Lau B; Kumar S; Yan T; Burn J; Kennedy C; McLean J; Boyer M; McCaughan B; Kao S
    Lung Cancer; 2017 Sep; 111():75-78. PubMed ID: 28838403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
    Bovolato P; Casadio C; Billè A; Ardissone F; Santambrogio L; Ratto GB; Garofalo G; Bedini AV; Garassino M; Porcu L; Torri V; Pastorino U
    J Thorac Oncol; 2014 Mar; 9(3):390-6. PubMed ID: 24518090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
    Flores RM; Krug LM; Rosenzweig KE; Venkatraman E; Vincent A; Heelan R; Akhurst T; Rusch VW
    J Thorac Oncol; 2006 May; 1(4):289-95. PubMed ID: 17409872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients.
    Sugarbaker DJ; Richards WG; Bueno R
    Ann Surg; 2014 Oct; 260(4):577-80; discussion 580-2. PubMed ID: 25203873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
    Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
    Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study.
    Spaggiari L; Marulli G; Bovolato P; Alloisio M; Pagan V; Oliaro A; Ratto GB; Facciolo F; Sacco R; Brambilla D; Maisonneuve P; Mucilli F; Alessandrini G; Leoncini G; Ruffini E; Fontana P; Infante M; Pariscenti GL; Casiraghi M; Rea F
    Ann Thorac Surg; 2014 Jun; 97(6):1859-65. PubMed ID: 24726598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
    Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.
    Bölükbas S; Eberlein M; Fisseler-Eckhoff A; Schirren J
    Lung Cancer; 2013 Aug; 81(2):241-6. PubMed ID: 23688589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
    Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.
    Rena O; Casadio C
    Lung Cancer; 2012 Jul; 77(1):151-5. PubMed ID: 22244608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
    Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
    Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.